Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evrysdi
Pharma
Roche picks up FDA nod for easier Evrysdi dosing format in SMA
A new FDA approval for a simpler Evrysdi administration route could give Roche's med a convenience edge over SMA rivals from Biogen and Novartis.
Fraiser Kansteiner
Feb 12, 2025 2:30pm
Roche files patent suit to fend off potential Evrysdi generics
Nov 20, 2024 9:44am
Biogen reports promising results for higher dose of Spinraza
Oct 9, 2024 7:30am
Biogen to seek approval for high-dose version of Spinraza
Sep 4, 2024 11:45am
Royalty commits up to $1.5B for most of PTC's Evrysdi royalties
Oct 19, 2023 11:13am
Genentech doubles up on Double Take, rebooting SMA fashion event
Jun 6, 2023 7:55am
